Key Breast Journal Articles - Neoadjuvant

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
OC Freedman, E Amir, W Hanna, F O'Malley, G Dranitsaris, DEC Cole, S Verma, E Folkerd, M Dowsett & M Clemons
Breast Cancer Res Treat. Sep 2009; 119(1):155-161
Journal

New results from the use of bisphosphonates in cancer patients
R Coleman & M Gnant
Curr Opin Support Palliat Care. Sep 2009; 3(3):213-218
Journal

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902
JGH van Nes, H Putter, J-P Julien, M Tubiana-Hulin, M van de Vijver, J Bogaerts, M de Vos, CJH van de Velde & Cooperating Investigators of the EORTC
Breast Cancer Res Treat. May 2009; 115(1):101-113
Journal

Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: primary efficacy analysis of the NOAH trial
L Gianni, W eiermann, V Semiglazov, G Manikhas, A Lluch, S Tjulandin, A Feyereislova, P Valagussa & J Baselga
Cancer Res. Jan 15 2009; 69(31 Supp)
Journal

The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer
MC Winter, HC Thorpe, R Burkinshaw, SJ Beevers & RE Coleman
Cancer Res. Jan 15 2009; 69(5101 Supp)
Journal

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
P Rastogi, SJ Anderson, HD Bear, CE Geyer, MS Kahlenberg, A Robidoux, RG Margolese, JL Hoehn, VG Vogel, SR Dakhil, D Tamkus, KM King, ER Pajon, MJ Wright, J Robert, S Paik, EP Mamounas & N Wolmark
JCO. Feb 10 2008; 26(5): 778-785
Journal

Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH): Antitumour and safety analysis
L Gianni, V Semiglazov, GM Manikhas, W Eiermann, A Lluch, S Tjulandin, A Feyereislova, B Vanhauwere, P Valagussa & J Baselga
JCO. June 20 2007; 25(18 Supp):532
Journal

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
VF Semiglazov, VV Semiglazov, GA Dashyan, EK Ziltsova, VG Ivanov, AA Bozhok, OA Melnikova, RM Paltuev, A Kletzel & LM Berstein
Cancer. May 30 2007; 110(2): 244-254
Journal

Neoadjuvant endocrine therapy in breast cancer
MJ Beresford, D Ravichandran & A Makris
Cancer Treat Rev. Feb 2007; 33(1):48-57
Journal

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear, S Anderson, RE Smith, CE Geyer Jr, EP Mamounas, B Fisher, AM Brown, A Robidoux, R Margolese, MS Kahlenberg, S Paik, A Soran, DL Wickerham, & N Wolmark
JCO. May 1 2006; 24(13):2019-27
Journal

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
M Kaufmann, GN Hortobagyi, A Goldhirsch, S Scholl, A Makris, P Valagussa, JU Blohmer, W Eiermann, R Jackesz, W Jonat, A Lebeau, S Loibl, W Miller, S Seeber, V Semiglazov, R Smith, R Souchon, V Stearns, M Untch, & G von Minckwitz
JCO. Apr 20 2006; 24(12):1940-49
Journal | Pubmed

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
MC Green, AU Buzdar, T Smith, NK Ibrahim, V Valero, MF Rosales, M Cristofanilli, DJ Booser, L Pusztai, E Rivera, RL Theriault, C Carter, D Frye, KK Hunt, WF Symmans, EA Strom, AA Sahin, W Sikov & GN Hortobagyi
JCO Early Release. Aug 8 2005
Journal

Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial
IE Smith, M Dowsett, SR Ebbs, JM Dixon, A Skene, J-U Blohmer, SE Ashley, S Francis, I Boeddinghaus & G Walsh
JCO. Aug 1 2005; 23(22):5108-5116
Journal

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, L Pusztai, MC Green, BK Arun, SH Giordano, M Cristofanilli, DK Frye, TL Smith, KK Hunt, SE Singletary, AA Sahin, MS Ewer, TA Buchholz, D Berry, & GN Hortobagyi
JCO. Jun 1 2005; 23(16):3676-85
Journal

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
OC Freedman, S Verma & MJ Clemons
Cancer Treat Rev. Feb 2005; 31(1):1-17
Journal

Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
D Mauri, N Pavlidis & JPA Ioannidis
J Natl Cancer Inst. 2005; 97(3):188-194
Journal

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear, S Anderson, A Brown, R Smith, EP Mamounas, B Fisher, R Margolese, H Theoret, A Soran, DL Wickerham, & N Wolmark
JCO. Nov 15 2003; 21(22):4165-74
Journal | Pubmed

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel
IC Smith, SD Heys, AW Hutcheon, ID Miller, S Payne, FJ Gilbert, AK Ah-See, O Eremin, LG Walker, TK Sarkar, SP Eggleton & KN Ogston
JCO. Mar 2002; 20(6):1456-66
Journal | Pubmed

Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902
JA van der Hage, CJH van de Velde, J-P Julien, M Tubiana-Hulin, C Vandervelden, Luc Duchateau & Cooperating Investigators
JCO. Nov 2001; 19(22):4224-37
Journal | Pubmed

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
W Eirmann, S Paepke, J Appfelstaedt, A Llombart-Cussac, J Eremin, J Vinholes, L Mauriac, M Ellis, M Lassus, HA Chaudri-Ross, M Dugan, M Borgs & V Semiglazov
Ann Oncol. 2001; 12:1527-32
Journal

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, ER Fisher, DL Wickerham, M Begovic, A DeCillis, A Robidoux, RG Margolese, AB Cruz Jr, JL Hoehn, AW Lees, NV Dimitrov & HD Bear
JCO. 1998; 16:2672-85
Journal